Total Payments
$5,563
2024 Payments
$532.33
Companies
40
Transactions
146
Medicare Patients
3,883
Medicare Billing
$231,539
Payment Breakdown by Category
Food & Beverage$3,042 (54.7%)
Consulting$1,695 (30.5%)
Education$826.08 (14.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,042 | 133 | 54.7% |
| Consulting Fee | $1,695 | 1 | 30.5% |
| Education | $826.08 | 12 | 14.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $1,967 | 7 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $671.29 | 20 | $0 (2024) |
| Lilly USA, LLC | $282.15 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $274.01 | 7 | $0 (2022) |
| Incyte Corporation | $243.41 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $209.86 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $192.79 | 11 | $0 (2024) |
| Amgen Inc. | $173.11 | 7 | $0 (2020) |
| Merck Sharp & Dohme LLC | $166.91 | 10 | $0 (2022) |
| Daiichi Sankyo Inc. | $128.01 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $532.33 | 7 | AstraZeneca Pharmaceuticals LP ($135.94) |
| 2023 | $152.69 | 2 | AstraZeneca Pharmaceuticals LP ($135.00) |
| 2022 | $702.69 | 28 | AstraZeneca Pharmaceuticals LP ($157.89) |
| 2021 | $75.04 | 5 | Novartis Pharmaceuticals Corporation ($47.10) |
| 2020 | $2,515 | 50 | Celgene Corporation ($1,695) |
| 2019 | $1,115 | 49 | Celgene Corporation ($158.06) |
| 2018 | $291.81 | 3 | Janssen Biotech, Inc. ($193.94) |
| 2017 | $178.22 | 2 | Celgene Corporation ($114.23) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $29.66 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $135.94 | General |
| Category: Oncology | ||||||
| 06/01/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $70.29 | General |
| Category: Oncology | ||||||
| 03/21/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Devices | ||||||
| 03/18/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $95.00 | General |
| 01/11/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $46.81 | General |
| 06/03/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 05/02/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Interventional Oncology | ||||||
| 10/27/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Oncology | ||||||
| 10/03/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 09/15/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Oncology | ||||||
| 09/14/2022 | PFIZER INC. | BOSULIF (Drug), BESPONSA, PAXLOVID | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 09/13/2022 | Lilly USA, LLC | CYRAMZA (Drug), RETEVMO | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Oncology | ||||||
| 09/13/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Oncology | ||||||
| 09/07/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Oncology | ||||||
| 09/06/2022 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 08/31/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Oncology | ||||||
| 08/31/2022 | Incyte Corporation | MONJUVI (Drug), JAKAFI, PEMAZYRE | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Oncology | ||||||
| 08/29/2022 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Oncology | ||||||
| 08/25/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: ONCOLOGY | ||||||
| 08/24/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Oncology | ||||||
| 08/18/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2022 | Sobi, Inc | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/08/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,400 | 7,572 | $227,583 | $76,053 |
| 2022 | 23 | 1,044 | 1,914 | $161,057 | $53,738 |
| 2021 | 20 | 719 | 1,241 | $112,695 | $35,636 |
| 2020 | 24 | 720 | 2,822 | $219,921 | $66,113 |
Total Patients
3,883
Total Services
13,549
Medicare Billing
$231,539
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 229 | $62,746 | $23,874 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 93 | $34,038 | $14,681 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $28,840 | $10,026 | 34.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 145 | 359 | $5,385 | $2,999 | 55.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 121 | 264 | $10,560 | $2,732 | 25.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 143 | 333 | $10,656 | $2,527 | 23.7% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 58 | 273 | $10,374 | $2,488 | 24.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 20 | 41 | $9,840 | $2,486 | 25.3% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 47 | 121 | $6,292 | $2,048 | 32.5% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Office | 2023 | 54 | 82 | $6,150 | $1,795 | 29.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 72 | 124 | $6,944 | $1,657 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 19 | $3,572 | $1,454 | 40.7% |
| 83550 | Iron binding capacity | Office | 2023 | 72 | 124 | $4,464 | $1,063 | 23.8% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 90 | 172 | $4,300 | $1,018 | 23.7% |
| 84165 | Protein measurement, serum | Office | 2023 | 54 | 82 | $2,952 | $863.46 | 29.3% |
| 83540 | Iron level | Office | 2023 | 72 | 124 | $3,348 | $786.16 | 23.5% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 11 | 4,800 | $4,800 | $778.78 | 16.2% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 11 | 25 | $1,850 | $439.27 | 23.7% |
| 83010 | Haptoglobin (serum protein) level | Office | 2023 | 27 | 29 | $1,508 | $357.57 | 23.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 30 | $2,160 | $335.36 | 15.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 17 | 21 | $1,302 | $310.38 | 23.8% |
| 82746 | Folic acid level, serum | Office | 2023 | 16 | 21 | $1,281 | $302.61 | 23.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 12 | 14 | $1,064 | $252.28 | 23.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 11 | 13 | $897.00 | $213.98 | 23.9% |
| 84155 | Total protein level, blood | Office | 2023 | 34 | 40 | $600.00 | $144.00 | 24.0% |
About Dr. Bilal Farooqi, MD
Dr. Bilal Farooqi, MD is a Hematology & Oncology healthcare provider based in Suffern, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1467891333.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bilal Farooqi, MD has received a total of $5,563 in payments from pharmaceutical and medical device companies, with $532.33 received in 2024. These payments were reported across 146 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,042).
As a Medicare-enrolled provider, Farooqi has provided services to 3,883 Medicare beneficiaries, totaling 13,549 services with total Medicare billing of $231,539. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Suffern, NY
- Active Since 06/24/2013
- Last Updated 12/19/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1467891333
Products in Payments
- REBLOZYL (Biological) $1,695
- CALQUENCE (Drug) $457.21
- KEYTRUDA (Biological) $132.59
- DARZALEX (Biological) $129.88
- IMBRUVICA (Drug) $128.39
- Revlimid (Drug) $127.56
- VERZENIO (Drug) $126.12
- GORE VIABAHN VBX Balloon Expandable Endo (Device) $125.00
- Pomalyst (Drug) $115.85
- Rubraca (Drug) $115.52
- INJECTAFER (Drug) $113.76
- IMFINZI (Drug) $107.01
- BRUKINSA (Drug) $96.01
- PROMACTA (Drug) $79.10
- CYRAMZA (Drug) $69.71
- GILOTRIF (Drug) $55.13
- Nexavar (Drug) $53.15
- LYNPARZA (Drug) $53.03
- SOMATULINE DEPOT (Drug) $51.21
- FOUNDATIONONE (Device) $46.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.